| 000 | 01873 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515020625.0 | ||
| 264 | 0 | _c20060612 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrusamolino, Ercole | |
| 245 | 0 | 0 |
_aDose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity. _h[electronic resource] |
| 260 |
_bHaematologica _cApr 2006 |
||
| 300 |
_a496-502 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFilgrastim |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xcomplications |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolyethylene Glycols |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aRusconi, Chiara | |
| 700 | 1 | _aMontalbetti, Luigi | |
| 700 | 1 | _aGargantini, Livio | |
| 700 | 1 | _aUziel, Lilj | |
| 700 | 1 | _aPinotti, Graziella | |
| 700 | 1 | _aFava, Sergio | |
| 700 | 1 | _aRigacci, Luigi | |
| 700 | 1 | _aPagnucco, Guido | |
| 700 | 1 | _aPascutto, Cristiana | |
| 700 | 1 | _aMorra, Enrica | |
| 700 | 1 | _aLazzarino, Mario | |
| 773 | 0 |
_tHaematologica _gvol. 91 _gno. 4 _gp. 496-502 |
|
| 999 |
_c16145969 _d16145969 |
||